GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 907 filers reported holding GLAXOSMITHKLINE PLC in Q4 2021. The put-call ratio across all filers is 0.21 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $81,503,000 | -0.9% | 1,872,325 | -0.8% | 0.02% | +21.4% |
| Q1 2022 | $82,250,000 | -10.6% | 1,888,224 | -9.5% | 0.01% | -6.7% |
| Q4 2021 | $91,981,000 | +28.2% | 2,085,708 | +11.1% | 0.02% | +15.4% |
| Q3 2021 | $71,726,000 | -13.1% | 1,877,140 | -9.4% | 0.01% | -13.3% |
| Q2 2021 | $82,516,000 | -10.3% | 2,072,255 | -19.6% | 0.02% | -11.8% |
| Q1 2021 | $92,003,000 | +1.6% | 2,577,859 | +4.8% | 0.02% | -5.6% |
| Q4 2020 | $90,525,000 | -6.6% | 2,459,884 | -4.5% | 0.02% | -14.3% |
| Q3 2020 | $96,926,000 | -7.3% | 2,575,112 | +0.4% | 0.02% | -16.0% |
| Q2 2020 | $104,581,000 | +2.5% | 2,563,893 | -4.8% | 0.02% | -13.8% |
| Q1 2020 | $102,041,000 | -21.4% | 2,693,079 | -2.5% | 0.03% | 0.0% |
| Q4 2019 | $129,832,000 | +12.1% | 2,762,969 | +1.8% | 0.03% | +3.6% |
| Q3 2019 | $115,827,000 | +9.7% | 2,713,855 | +2.8% | 0.03% | +12.0% |
| Q2 2019 | $105,624,000 | -4.6% | 2,639,292 | -0.4% | 0.02% | -7.4% |
| Q1 2019 | $110,761,000 | +3.2% | 2,650,420 | -5.6% | 0.03% | -10.0% |
| Q4 2018 | $107,292,000 | -9.3% | 2,807,971 | -4.7% | 0.03% | +3.4% |
| Q3 2018 | $118,343,000 | +2.2% | 2,946,078 | +2.6% | 0.03% | 0.0% |
| Q2 2018 | $115,758,000 | -7.6% | 2,871,728 | -10.4% | 0.03% | -12.1% |
| Q1 2018 | $125,284,000 | +21.8% | 3,206,664 | +10.6% | 0.03% | +26.9% |
| Q4 2017 | $102,871,000 | -17.5% | 2,900,223 | -5.6% | 0.03% | -18.8% |
| Q3 2017 | $124,699,000 | -6.1% | 3,071,400 | -0.2% | 0.03% | -13.5% |
| Q2 2017 | $132,743,000 | +5.2% | 3,078,478 | +2.9% | 0.04% | +2.8% |
| Q1 2017 | $126,171,000 | +10.7% | 2,992,648 | +1.1% | 0.04% | +2.9% |
| Q4 2016 | $114,006,000 | +30.2% | 2,960,422 | +45.9% | 0.04% | +29.6% |
| Q3 2016 | $87,529,000 | +1.4% | 2,029,429 | +1.9% | 0.03% | -3.6% |
| Q2 2016 | $86,289,000 | -3.5% | 1,990,993 | -9.8% | 0.03% | -6.7% |
| Q1 2016 | $89,432,000 | +3.3% | 2,206,431 | +2.8% | 0.03% | +3.4% |
| Q4 2015 | $86,598,000 | -0.6% | 2,146,187 | -5.3% | 0.03% | 0.0% |
| Q3 2015 | $87,137,000 | -1.6% | 2,266,232 | +6.6% | 0.03% | +7.4% |
| Q2 2015 | $88,573,000 | -5.8% | 2,126,628 | +4.4% | 0.03% | -3.6% |
| Q1 2015 | $94,036,000 | +16.6% | 2,037,607 | +8.0% | 0.03% | +16.7% |
| Q4 2014 | $80,650,000 | +38.3% | 1,886,996 | +48.7% | 0.02% | +33.3% |
| Q3 2014 | $58,323,000 | -68.6% | 1,268,719 | -63.4% | 0.02% | -69.0% |
| Q2 2014 | $185,502,000 | +39.4% | 3,468,624 | +39.2% | 0.06% | +38.1% |
| Q1 2014 | $133,107,000 | +21.2% | 2,491,228 | +21.1% | 0.04% | +20.0% |
| Q4 2013 | $109,789,000 | +8.9% | 2,056,359 | +2.3% | 0.04% | -2.8% |
| Q3 2013 | $100,822,000 | +2.6% | 2,009,602 | +2.2% | 0.04% | 0.0% |
| Q2 2013 | $98,306,000 | – | 1,967,297 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |